Darboren 25 mcg/0.42 ml
- Generic
- Darbepoetin Alfa
- Manufacturer
- Square Pharmaceuticals Ltd.
- Drug class
- Haematopoietic Agents
- Pregnancy category
- C
Price
৳2,800 per 25 mcg pre-filled syringe
Packs & prices
- 25 mcg pre-filled syringe৳2,800
This is information only. Do not start, stop or switch medicines without a doctor's advice.
Warnings
Contraindications
- Uncontrolled hypertension
- Pure red cell aplasia (PRCA) that begins after treatment with Darbepoetin or other erythropoietin protein drugs
- Serious allergic reactions to Darbepoetin
Precautions
Side effects
Pregnancy & lactation
Drug interactions
More information
Indications
Anemia Due To Chemotherapy In Patients With Cancer: Darbepoetin Alfa is indicated for the treatment of anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy.
Dosage
- Initial dose: 0.45 mcg/kg IV or subcutaneously once every 4 weeks as appropriate
- Comments: Initiate treatment only when hemoglobin is less than 10 g/dL, rate of hemoglobin decline indicates likelihood of requiring RBC transfusion, and reducing risk of alloimmunization and/or other RBC transfusion-related risks is a goal.
- Initial dose: 0.45 mcg/kg IV or subcutaneously once a week or 0.75 mcg/kg once every 2 weeks as appropriate
- Comments: Initiate treatment when hemoglobin is less than 10 g/dL. IV route is recommended for patients on hemodialysis.
Usual Adult Dose for Anemia Associated with Chemotherapy:
- Initial dose: 2.25 mcg/kg subcutaneously once a week or 500 mcg subcutaneously once every 3 weeks
- Duration of therapy: Until completion of chemotherapy course
- Comments: Initiate treatment if hemoglobin is less than 10 g/dL and a minimum of 2 additional months of chemotherapy is planned. Use the lowest dose necessary to avoid RBC transfusions.
- Use: Treatment of anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitant myelosuppressive chemotherapy.
Use in children
- Pediatric Patients With CKD: Darbepoetin safety and efficacy were similar between adults and pediatric patients with CKD when Darbepoetin was used for initial treatment of anemia or patients were transitioned from treatment with epoetin alfa to Darbepoetin
- Pediatric Patients With Cancer: The safety and efficacy of Darbepoetin in pediatric patients with cancer have not been established.
Overdose
Pharmacology
Therapeutic class
Storage
Source: medex.com.bd · Prescribing information (PDF)
Cheaper alternatives
Same generic, strength and form — sorted by price
Darbesis
Beacon Pharmaceuticals Ltd.
৳2,840 / 25 mcg pre-filled syringe
৳40 more
Darbetin
Healthcare Pharmaceuticals Ltd.
৳2,840.71 / 25 mcg pre-filled syringe
৳40.71 more
Bottle/tube prices depend on size — compare quantities before switching.